Spero Therapeutics, Inc.SPRONASDAQ
Loading
Direct costs attributable to producing goods sold
5Y CAGR
+10.1%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
1.6x
Solid growth
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $108.24M | +11.9% |
| 2024 | $96.76M | +88.1% |
| 2023 | $51.44M | - |
| 2022 | $0.00 | - |
| 2021 | $0.00 | -100.0% |
| 2020 | $67.00M | +1.9% |
| 2019 | $65.78M | +94.1% |
| 2018 | $33.88M | +3.1% |
| 2017 | $32.87M | +24.8% |
| 2016 | $26.33M | - |